About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04186767

Weight Loss Impact on Male Fertility

This is a prospective non-randomized unicentric clinical trial, characterized by the inclusion of obese (BMI\> 35) male with subfertility (sperm count showing low sperm counts and / or motility and / ...

Lead sponsor: University of Sao Paulo•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Sao Paulo

Age

18 - 55 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Obesity in male patients
•Metabolic Syndrome (NCEP-ATP III)
•Alteration of some of the seminal parameters evaluated in conventional seminal analysis

Exclusion Criteria

•Other causes of hypogonadotrophic hypogonadism
•* Hypergonadotrophic hypogonadism
•* Contraindications for performance of ketogenic diet:
•* Type 1 or type 2 diabetes mellitus in insulin use
•* Food drive
•* Alcoholism or drug addiction
•* Severe psychiatric illness
•* Use of coumarin anticoagulants
•* Hepatic insufficiency
•* Severe renal impairment
•* Hematologic diseases
•* Cancer in activity,
•* Cardiovascular or cerebrovascular diseases (arrhythmias, recent myocardial infarction, unstable angina, decompensated heart failure, recent stroke)
•* Gout
•* Renal or biliary lithiasis
•* Major depression or other serious psychiatric illness.

Related studies

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 28, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment20

Start dateJan 2019

Last updatedFeb 28, 2023

Condition

Obesity Sub Fertility, Male Metabolic Syndrome

Locations shown

Hospital das Clinicas da Faculdade de Medicina da USP

São Paulo, São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 28, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions